Great presentation today @AcademicSurgery by Natalie Chakraborty starting to understand the value of sentinel node biopsy in Elderly patients with melanoma. More to come! @UHSurgeryRes @Richard_Hoehn

We are honored to have received the renewal of our Comprehensive Cancer Center designation from @theNCI. This important recognition allows us and our partners—@CWRUSOM, @UHhospitals & @ClevelandClinic—to fund innovative cancer research that saves lives. https://t.co/KOqf0RK2pC

So lucky to have a GI immunotherapy expert and advocate here at @UHhospitals @doctorC369

Join us in congratulating @JoeSabik, MD, Chair of Department of Surgery, University Hospitals, on this exceptional and well-deserved honor.

So glad our hard work is published at Gastroenterology @AGA_Gastro. Cancer sucks but we do our part to fight back. Shout out to my awesome team and all the collaborators and mentors @cwru @caseccc @UHhospitals @SurgeryUH @UH_RE_Institute https://t.co/PFUX0tTEd1

Calling all medical students applying to general surgery! Join us Monday for our open house! @BehindTheKnife @AmCollSurgeons @TheNRMP @Inside_TheMatch @FutureGenSurg #gensurgmatch2025 #Match2025 #Gensurgmach

If you're headed to the plenary session on metabolism at #AACRpan24, check out this article by @MehrdadZarei15, @JordanMWinterMD, and colleagues: #IDH1 Inhibition Potentiates #Chemotherapy Efficacy in #PancreaticCancer. https://t.co/cj3eo1usxZ @winterlab8 #openaccess

Join us for an open house to meet our residents, learn about our program, and ask questions! We look forward to meeting all the #GensurgMatch2025 applicants! @TheNRMP @Inside_TheMatch @AmCollSurgeons @FutureGenSurg

#ScienceSaturday The combination of anti-CTLA-4 and anti-PD-1 antibodies is FDA approved for the treatment of advanced #melanoma. How does this combination work mechanistically? In a recently published study in @Cancer_Cell using both single cell TCR and RNA sequencing, Wang

Spotlight on the neoadjuvant use of BRAF-MEK Inhibitors in Melanoma. @rutkowskip1972 @Czarneck @UH_RE_Institute @CWRUSOM @caseccc @CureMelanoma @AIMatMelanoma. Thank you @cure_today for the opportunity to discuss this important study.

@AnkitmanglaMD of @CWRUSOM spoke with CURE® about BRAF and MEK inhibitors and how they work for certain patients with stage 3 or stage 4 #Melanoma. https://t.co/FagyMiAHCb

Fantastic day for Winter Lab!🥳Congrats to our amazing BOSS @Jordanwinter for being named Executive Vice Chair of UH Surgery Dept. Your passion for patients and science is truly inspiring. We’re honored to be part of this journey with you. @UH_RE_Institute @UHSurgeryRes @caseccc

Skin cancer is by far the most commonly diagnosed cancer, but it is also one of the most preventable types of cancer. Surgical oncologist and @AmColSurgCancer State Chair @JeffreyFarma shares his top 3 tips on protecting your skin this summer ☀️ 🔗: https://t.co/XZH1oATPGh

Jonathan Zager, MD (@jzager99) presents on the FOCUS study for metastatic uveal melanoma to the liver during #ASCO24. Moffitt is proud to have led this Phase 3 trial which led to the recent @US_FDA approval. #MoffittASCO24

Join Case CCC Director Gary Schwartz, MD, for "The Treatment of Soft Tissue and Bone Sarcomas: The Interaction Between Genomics and Cancer Therapeutics" on Tuesday, May 21, at 3 p.m. ET via Zoom: https://t.co/Q5Hv0qHzzz

This guy @HannaKakish has developed masterful skills in presenting his research! @UHSurgOncology @UHRISES It has been a pleasure to train him. He is bringing a great skillset to @hopkinssurgery, and he will be missed here @UHSurgeryRes

please share the link and connect us with talented psotdoc. #hiring #postdoc #cancerresearch Postdoctoral Fellow in cancer research

From #AACR24 presentation to @AACR recap, this team is always hard at work, having fun, and dedicated to advancing pancreatic cancer treatments. Big thanks to @JordanMWinterMD for bringing this group together and leading them like the stars they are! 🌟 @caseccc @UHhospitals

#Neoadjuvant therapy for #melanoma is the new kid on the block. Our analysis provides guidance on the choice of regimen. Read on! https://t.co/s0XgH6Nr2O Doctors Weigh Patient Goals Instead of ‘Dictating’ Melanoma Treatment https://t.co/oHVyH8JRmk via @cure_today

Luke Rothermel, MD, MPH joins us as the next #ResearcherSpotlight! @LukeRothermel is an Assistant Professor of Surgery here at @UHSurgOncology. Follow along to learn more about his research in CLE!